PAC Study Tour, Egypt December 2007          Safe international had selected three doctors and one sister (Dr Basheer Aljeyli. Dr Atif Fazari, Sister Amira Elnour and Dr. Tag Elsir Mohamed Ali) in cooperation with PPFA & Gynuity Health Projects to participate in Misoprostol Study at AL-Shatby hospital (Alexandria) and Algala hospital (Cairo) The Sudanese PAC network team knows about use of Misoprostol on incomplete abortion The Study had been very useful and informative; the study tour covered all aspects of clinical use of Misoprostol and the protocol of Misoprostol study in treating incomplete abortion at Shatby and Algala hospitals. We realize that it covered our needs, it is very relevant to the work in Sudan, and it can be applicable in our country. It was been a pleasure to meet that a wonderful staff at Shatby hospital and Dr. Mohamed Sherine (Algala hospital), the consultant Dr.Nevine Hassanein and Rasha Dabash from Gynuity Health Projects. PAC Network team attended presentations on Egyptian experience The three days of the study tour had been enjoyable with excellent accommodation and very pleased discussions and planning.  I had been presented a current situation of PAC in Sudan and it took a broad & useful discussion. We discussed the following points:     There is a demand to integrate Misoprostol in PAC services and protocol as had already begun with MVA. While Misoprostol is not registered or officially available in Sudan, it is widely available and used frequently for wide range of RH indications Dr. Mohamed Cherine and Dr.Nevine Hassanein will travel to the Sudan for 2-3 days at the second half of February. There will meet with the key policy persons to discuss the integration of Misoprostol into the broader PAC strategy for the Sudan, they will also visit 2-3 hospitals in Khartoum and one state hospital (Madany hospital) to select tow hospitals that will likely the study will took place first. Gynuity will develop operational research on Misoprostol to collect statistical data in collaboration with Safe International. They had been a discussion to invite some key person from MOH to attend the national dissemination meetings in Egypt on Misoprostol for PPH treatment & for Incomplete Abortion.